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This study was designed to investigate possible prevention of apoptotic cell death by selenium, an antioxidant, using cultured brain-derived
neural progenitor cells (NPCs) and an experimental mouse brain trauma (BT) model. We tested some of the neuroprotective effects of sodium
selenite in NPC cells by monitoring thioredoxin reductase (TR) expression, optimum H2O2 removal, and consequent inhibition of pro-apoptotic
events including cytochrome c release and caspase 3 and 9 activation. Analysis of key apoptotic regulators during H2O2-induced apoptosis of
NPCs showed that selenite blocks the activation of c-jun N-terminal protein kinase (JNK)/P38 mitogen-activated protein kinase (MAPK), and Akt
survival protein. Moreover, selenite activates p44/42 MAPK and inhibits the downregulation of Bcl2 in selenite-treated NPC cells. For in vivo
experiments, the effects of selenite on H2O2 neurotoxicity were tested using several biochemical and morphologic markers. Here we show that
selenite potentially inhibits H2O2-induced apoptosis of NPCs and in traumatic brain injury. This in vivo protective function was also associated
with inhibition of H2O2-induced reactive oxygen species (ROS) generation, cytochrome c release and caspase 3 and 9 activation. Our data show
that the protective function of selenite through attenuation of secondary pathological events most likely results from its comprehensive effects that
block apoptotic cell death, resulting in the maintenance of functional neurons and in inhibition of astrogliosis. The finding that selenite
administration prevents secondary pathological events in an animal model of traumatic brain injury, as well as its efficacy, may provide novel drug
targets for treating brain trauma.
© 2007 Elsevier B.V. All rights reserved.Keywords: Brain trauma; Hydrogen peroxide; Neuroprotection; Oxidation; Sodium selenite1. Introduction
Traumatic brain injury not only causes direct mechanical
damage to tissue, but also induces biochemical changes that lead
to delayed neural cell loss [1]. It has been increasingly
recognized that such secondary injury may make substantial
contributors to chronic neurological disability [2]. Traumatic
brain injury is one of the oxidative injuries that also have been
linked causally to a variety of neurodegenerative diseases,
including Alzheimer's disease [3], Parkinson's disease [4], and
amyotropic lateral sclerosis [5], as well as spinal cord injuries
and conditions such as ischemia and excitotoxicity. Oxidative⁎ Corresponding author. Tel.: +82 51 240 7961; fax: +82 51 246 6001.
E-mail address: skkang@pusan.ac.kr (S.K. Kang).
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doi:10.1016/j.bbadis.2007.09.004damage is mediated by reactive oxygen species (ROS), which
can be generated following cell lysis, oxidative burst (as part of
the immune response) [6,7] or the presence of an excess of free
transition metals (which can act catalytically to generate free
radicals) [8]. ROS can also be generated as a byproduct of
normal cellular respiration, primarily associated with mitochon-
drial electron transport [9]. Cellular defense mechanisms against
oxidative damage include enzymatic conversion of ROS to less
reactive species, chelation of transition metal catalysts and
detoxification of ROS by antioxidants [10]. Imbalances in the
production of ROS and the actions of protectionmechanisms can
lead to cell experiencing excessive direct exposure to ROS, and
subsequent free radical-induced damage. These damaging
effects are normally kept under control by endogenous
antioxidant systems including glutathione, ascorbic acid, and
enzymes such as superoxide dismutase, glutathione peroxidase,
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are overwhelmed by ROS, and the resulting oxidative damage
can lead to cell death. Neural stem/progenitor cells (NS/PCs) are
very sensitive to increases of ROS and this sensitivity results in
cell apoptosis. Oxidative stress-induced apoptosis in NS/PCs
has often been observed during NS cell therapy and therapeutic
irradiation of brain [11]. These findings suggest that oxidative
damage to mitochondria is a critical event in oxidative cell
damage, and mitochondrial ROS should be a primary target for
drug development [11,12]. A number of proapoptotic and
antiapoptotic proteins are present in the mitochondrial mem-
brane. Cytochrome c, a component of the respiratory chain, has
been identified as a proapoptotic molecule present in the
mitochondria [12]. The release of cytochrome c from the injured
mitochondria was recently shown to activate caspase-3 [13].
Bcl-2 is an antiapoptotic protein, which is predominantly present
in mitochondria, and prevents apoptosis induced by various
agents [14,15]. Bcl-2 prevents cell death by suppressing
oxyradical-mediated membrane damage, stabilizing mitochon-
drial membrane potential, and preventing the release of
cytochrome c release [16,17].
Selenite, an essential dietary element for mammals, is known
to be present in the active center of glutathione peroxidase
(GPx), an antioxidant enzyme that protects membrane lipids
and macromolecules from oxidative damage produced by
peroxides [18,19]. Selenium is also required for the catalytic
activity of mammalian thioredoxin reductase, another important
anti-oxidant enzyme [21,22]. In addition, selenium has been
shown to protect against methamphetamine-induced neurotox-
icity [23]. Moreover, positive clinical responses obtained during
therapy with selenium and other antioxidants in neurodegener-
ative diseases have provided substantial evidence for the
important role of free radicals and oxidative stress in pathologic
processes [24]. Neuroprotective effects of Se have been
reported at an experimental level in both methamphetamine-
[23] and 6-hydroxydopamine-induced toxicities, as well as in
positive clinical responses during therapy with selenite in
neurodegenerative diseases [24]. In a recent report, we de-
scribed some of the protective effects that selenite exerts on both
neurochemical and behavioral markers of H2O2-induced
neurotoxicity in neural progenitor cells derived from mouse
brain. Since these positive actions were related to redox
modulation as evidenced by decreased lipid peroxidation, we
hypothesized that these protective effects might directly involve
the antioxidant properties of selenite, most probably related to
thioredoxin reductase (TR) expression, optimum H2O2 remov-
al, and a consequent inhibition of pro-apoptotic events such as
caspase 3 and 9 activation. The present study was also designed
to investigate whether MAPK- and ERK-mediated signaling
pathways are involved in the anti-apoptotic effect of selenite
and whether selenite modulates Bcl2 and Bax expression during
apoptotic cell death in vitro and in vivo. We also detected the
effect of selenite on different markers of neurotoxicity and cell
death induced by ROS after traumatic damage in mouse brain in
vivo. For in vivo experiments, the effects of selenite on H2O2
neurotoxicity were tested using biochemical and morphologic
markers.2. Materials and methods
2.1. Brain-derived neural progenitor cells culture
For preparation of brain-derived NPCs, 4-week-old mice were killed by
decapitation. The region of the subventricle zone was dissected out. After
removal of the dura, the tissue was minced, washed in sterile Dulbecco's
phosphate-buffered saline and digested in a solution of 0.125% of trypsin, DNase
(0.01%, Sigma) in Hank's balanced salt solution for 30 min at 37 °C. The cells
were plated at a density of 5×105 in 10-cm dishes and cultured in serum-free
growth medium, which consists of NB (Neurobasal) medium with B27
supplement (Gibco), bFGF (basic fibroblastic growth factor, 10 ng/ml, Sigma),
and EGF (epidermal growth factor, 10 ng/ml, Sigma). For expansion of NPCs,
cells were grown as neurospheres in petri dish containing NB/B27 and cytokines
supplemented culture media [20]. For this study, we usually use 5 to 6 passage
NPC cells.
2.2. Sodium selenite treatment and H2O2 exposures
For experiment, brain-derived neural progenitors cells (NPCs) were seeded
in 10 cm culture dishes at a density of 5×105 and cultured in cytokine-free
NB/serum-free B27 supplement (B27 Cat No; 17504-044) media for 8 h in a
humidified chamber with 5% CO2. Cells were then pre-treated with sodium
selenic acid (Na2SeO3, Sigma) (2 ng/ml) for 8 h followed by H2O2 (0.03 μM/
ml, Sigma) in serum-free DMEM media for a further 6 h. We analyzed cell
viability by Tryphan blue exclusion method after 24 h culture. The optimum
concentrations of selenite and H2O2 were selected according to the preliminary
experiment related to cytotoxicity and survival effect of broad range of each
reagent. Dilutions of H2O2 were made fresh from a 30% stock solution into
DMEM just prior to each experiment. Exposures to H2O2 were performed by
simple addition of a small volume of H2O2 diluted in DMEM at ×100 directly
to each well, followed by light agitation. For western blotting, cultures were
incubated for the times noted, and then toxicity or biochemical measurements
were performed. We observed that the toxicity of H2O2 was reduced if the
H2O2 exposures were not performed within 5 min of dilution. This is likely
due to the highly reactive nature of H2O2 and its short half-life in dilute
solutions.
2.3. Analysis of cell viability
Cell viability was assessed by visual cell counts in conjunction with Tryphan
Blue exclusion. In all viability assays, triplicate wells were used for each
condition, and each experiment was repeated at least three times. For
flowcytometric analysis, cells were cultured in 100-mm dishes at densities that
ensured exponential growth at the time of harvest. The harvesting and processing
protocols used to detect DNA by flow cytometry with propidium iodide were
done. Cells were analyzed with a BD Biosciences FACScan (San Jose, CA).
Percentages of cells in the G0/G1, S, and G2/M stages of the cell cycle were
determined with a DNA histogram fitting program (MODFIT; Verity Software,
Topsham, ME). A minimum of 104 events /sample was collected. In all viability
assays, triplicate wells were used for each condition, and each experiment was
repeated at least three times. Raw data from each experiment were analyzed using
analysis of variance with Fisher or t-test.
2.4. RNA extraction and reverse transcription polymerase chain
reaction (RT-PCR)
For RT-PCR, hydrogen peroxide (0.03 μM/ml)-treated cells (selenium
pretreated or untreated cell) was cultured for 1 day and then total cellular RNA
was extracted with Trizol (Life Technologies, Frederick, MA), reverse
transcribed into first strand cDNA using an oligo-dT primer amplified by 35
cycles (94 °C, 1 min; 55 °C, 1 min; 72 °C, 1 min) of PCR using 20 pM of specific
primers. PCR amplification was performed using the primer sets. Duplicate PCR
reactions were amplified using primer designed GAPDH as a control for
assessing PCR efficiency and for subsequent analysis by 1.5% agarose gel
electrophoresis. For labeling of PCR products, we used a Syber green detection
kit which was purchased from Applied Biosystems (Foster, CA). Semi-
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Detection System. Primer sequences were designed using Primer Express
software (PE-Applied Biosystems, Warrington, UK) using gene sequences
obtained from the GeneBank database.Gene Forward sequence
(5′–3′)Reverse sequence
(3′–5′)GAPDH CATGACCACAGTC
CATGCCATCACTTGAGGTCCACCAC
CCTGTTGCTGTANestin AACTGGCACACCT
CAAGATGTTCAAGGGTATTAG
GCAAGGGGGFAP TCCGCCAAGCCAA
GCACGAAGCATCCCGCATCTC
CACAGTCTMMP1 ACAGTTTCCCTGT
GTTTCACAGTCACTTTCAGC
CCAAATAMMP2 CCTGATGTCCAGC
AAGTAGATGCTTAAGGTGGTGCA
GGTATCTGGGDNF ATTTTATTCAAGCC
ACCATTAGATACATCCACAC
CCTTTAGCSDF1 GTCCTCTTGCTGTC
CAGCTCGAAGGGCACAGTT
TGGAGTGTuj CCTTTGGACACCT
ATTCAGGGTGAGTGTGTCAG
CTGGAAGGDNF ATTTTATTCAAGCC
ACCATTAGATACATCCAAGC
CACCATTATrkβ TCTATGCCGTGGTG
GTGATTGCGCGTCTTCACAGC
CACCAGGATEGF ACCAGACGATGAT
GGGACAGGCCAGCACACACT
CATCTATVEGF CCTGGTGGACATC
TTCCAGGAGTACCGAAGCTCATCTCT
CCTATGTGCTGGCFGFR2 GAGGCTGTCTCAG
AGCCTGTCTTGCGGCTGTCC
ACTTATC2.5. TUNEL (TdT-mediated dUTP-X nick end labeling) and caspases
assays and quantification
The effect of traumatic damage on the induction of apoptosis brain tissue was
determined with the TdT in situ apoptosis detector kit (Roche, USA), used
according to the manufacturer's specifications. After fixation, injured tissue
sections with 4% paraformaldehyde were incubated in TUNEL reaction mixture
containing deoxynucleotidyl transferase (TdT) buffer with TdT and biotinylated
dUTP, incubated in a humid atmosphere at 37 °C for 90 min, and then washed
with PBS. The cells were incubated in TUNEL reaction mixture. And then
incubated secondary antibody conjugated with the fluorescent markers. The
results were analyzed using a Fluorescence Microscope (Leica Microsystem,
PA). TUNEL-positive apoptotic cells in brain lesion site were quantified by
counting of positively stained cells. Three digital microscopic images at a
magnification of 100× were randomly captured at the areas where the positive
cells were abundant around lesion site for each section. The number of positively
stained cells in the three images was averaged. The result was expressed as
relative cells percentage per view field under themicroscope. The size of the view
field was 0.075 mm2. Also, we measured Caspases activities in traumatic brain
tissue after 1 week of selenium treatment. For Caspase-3, -8, and -9 activity
assays, 10 μg of protein in 50 μl total volume was mixed with 50 μl of
equilibrated Caspase-Glo 3/7, 8, or 9 reagents (Promega). After incubating at
room temperature for 1 h, luminescence was measured using TD 20/20
Luminometer (Turner Designs, Sunnyvale, CA). Blank values were subtracted
and fold-increase in activity was calculated based on activity measured from
untreated cells. Each sample was measured in triplicate.
2.6. Measurement of intracellular ROS
Intracellular ROS was evaluated using the fluorescent probe DCFDA (5-
(and -6)-carboxy-2′, 7′-dichlorodihydrofluorescein diacetate, Sigma). For
visualization by fluorescent microscopy, NPC cells were plated in glass bottomdishes and treated with 0.03 μM H2O2, alone or with selenite (2 ng/ml), for 6 h.
Cells were then washed and loaded with 10 μM of DCFDA for 30 min at 37 °C,
and imaged by fluorescent microscopy (ex/em=495/525 nm). For quantitative
assessment of ROS production, brain-derived NPC cells in 96-well plates were
washed with HBSS and loaded with 10 μMof DCFDA for 30 min at 37 °C. Cells
were washed three times with HBSS and exposed to 100 ìM of tBHP (Sigma),
alone or with SS-31.
2.7. ATP measurement
The amount of protein was determined using the Protein Assay Kit (Bio-
Rad, Hercules, CA, USA) following the manufacturer's instructions. Cells were
resuspended in buffer containing 150 mmol/l KCl, 25 mmol/l Tris–HCl; pH 7.6,
2 mmol/l EDTA pH 7.4, 10 mmol/l KPO4 pH 7.4, 0.1 mmol/l MgCl2 and 0.1%
(w/v) BSA at a concentration of 1 mg protein per ml of buffer. ATP synthesis
was initiated by the addition of 250 μl of the cell suspension to 750 μl of
substrate buffer (10 mmol/l malate, 10 mmol/l pyruvate, 1 mmol/l ADP, 40 μg/
ml digitonin, and 0.15 mmol/l adenosine pentaphosphate). Cells were incubated
at 37 °C for 10 min. At 0 and 10 min, 50 μl aliquots of the reaction mixture were
withdrawn, quenched in 450 μl of boiling 100 mmol/l Tris–HCl, 4 mmol/
l EDTA (pH 7.75) for 2 min and further diluted 1/10 in the quenching buffer. The
quantity of ATP was measured in a luminometer (Berthold, Detection Systems,
Pforzheim, Germany) with the ATP Bioluminescence Assay Kit (Roche
Diagnostics, Basel, Switzerland) following the manufacturer's instructions.
2.8. Western blot
For confirmation of differentially expressed proteins after selenite treatment
in cultured NPC cells and traumatic injured brain, dissected brain lesion site
tissues from three or four injured or normal animals and selenite-treated cells
were pooled and homogenized (only tissue) and lysed in 500 μl of lysis buffer
(20 Mm Tris–HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
2.5 mM sodium pyrophosphate, 1 mM EGTA, 1 mM glycerophosphate, 1 mM
Na3VO4, and 1 mM PMSF, Sigma). Lysates were clarified by centrifugation at
15,000×g for 10 min and the total protein content was determined by a Bio-Rad
(Milan, Italy) protein assay kit. For western blotting, equal amounts (40 μg) of
protein extracts in a lysis buffer were subjected to 10% SDS-PAGE analysis and
transferred to a nitrocellulose membrane. Anti-GFAP, anti-Nestin (1:500,
Sigma), anti-MBP (1;400, Chemicon, USA), pSAPK/JNK (1:1000, Cell Sig-
naling), anti-pERK (1:1000, Cell Signaling), anti-Bcl2 (1:1000, Cell Signaling),
anti-Bax (1:1000, Cell Signaling), anti-P38 (1:1000, Cell Signaling), anti-Akt
(1:1000, Cell Signaling), anti-cytochrome c (1:1000, Cell Signaling), and anti-
β-Actin (1;500, Sigma) antibodies were incubated with membranes. Relative
band intensities were determined by Quality-one 1-D analysis software (Bio-
Rad, USA).
2.9. Brain traumatic injury induction and in vivo experimental design
Adult female ICRmouse weighing 30 g or 5-week-old mice were used in our
experiments. Animal care was in compliance with Korean regulations on pro-
tection and feeding of animals used for experimental and other scientific
purposes. Experimental mice were anesthetized with ketamine (75 mg/kg) and
xylazine (10 mg/kg). The animal was placed on a heated pad, and a core body
temperature was maintained at 38±0.2 °C. Mouse was transferred to a
stereotaxic apparatus in a clean field. A 2- to 5-mm incision was made in the
scalp 1.5 mm lateral to the bregma. A burr hole was made in the bone 3 mm
lateral to bregma with a dental drill. The drill tip was then positioned to the
surface of the exposed dura, and made impact and extended at a depth of 5 mm
cortical surface and made hall after cutting several time. To evaluate efficacy of
selenite, we treated selenite mixed with matrigel or matrigel only into lesion hall
of traumatic brain directly. And then, the incision was closed with interrupted 6-
0 silk sutures, anesthesia was terminated, and the animals were monitored
carefully for at least 4–5 h after surgery and then daily. For this study, we
collected enough tissues those were timely harvested for biochemical
examination. To evaluate the effect of sodium selenite on acute phase brain
trauma pathophysiology, traumatic mice were sacrified after 1 week of injection
and then we analyzed. Usually we use three group of mice (n=15) with brain
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selenite mixed with matrigel (Gibco-BRL) (n=15) and the control group
(n=10), vehicle or matrigel only. To evaluate the effect of selenite on acutic
pathogenic microenvironment of brain trauma (immediately after injury), the
mice with brain trauma received varying concentrations of drugs (0, 10, 30,
50 ng/kg) as treatment. Finally, we determined that the optimum selenite
concentration was determined for effective treatment of brain trauma mice.
2.10. Sodium selenite administration
Various concentrations of purified sodium selenite were dissolved in HBSS,
mixed according to the manufacturer's instructions with matrigel (Gibco-BRL)
(0, 10, 30, 50 ng/kg) and injected directly into the lesion site immediately afterFig. 1. Effects of sodium selenite on neural progenitor cell survival and growth followin
concentrations of H2O2 alone or with selenite pretreatment (2 ng/ml). To assess the effec
conjunction with trypan blue exclusion methods. In all viability assays, triplicate wells w
(B) Intracellular ROS was evaluated using the fluorescent probe DCFDA (5-(and-6)-
fluorescent microscopy, NPC cells were plated in glass bottom dishes and treated with 0
loaded with 10 μM of DCFDA for 30 min at 37 °C, and imaged by fluorescent microsc
derivedNPC cells in 96-well plateswere washedwithHBSS and loadedwith 10 μMofD
to 100 μMof tBHP (Sigma), alone or with SS-31. The oxidation of DCF (5-(and-6)-carinjury. The control (vehicle) group received the same volume of HBSS mixed
with matrigel only. The mice were randomly assigned into two groups: 25
trauma mice receiving the various concentrations of the drug treatment and 5
trauma mice as control. A total of 30 animals were used in these experiments.
Immediately after the brain trauma lesion, either the experimental treatment
(selenite mixed with matrigel) or the control treatment (HBSS mixed with
matrigel) was injected into the lesion cavity close to the cortex and some of
striatum of injured brain. The skin incision was closed with silk sutures.
2.11. Histological analysis
The animals were sacrified under sodium pentobarbital anesthetized
(60 mg/kg, ip) and their brain fixed by transcardial perfusion with 0.1 Mg H2O2-induced apoptotic cell death. (A) Cultured NPCs were treated with several
t of selenium on cell survival and proliferation, visual cell counts were performed in
ere used for each condition and each experiment was repeated at least three times.
carboxy-2′,7′-dichlorodihydrofluorescein diacetate, Sigma). For visualization by
.03 μMH2O2, alone or with selenite (2 ng/ml), for 6 h. Cells were then washed and
opy (ex/em=495/525 nm). For quantitative assessment of ROS production, brain-
CFDA for 30min at 37 °C. Cells were washed three timeswith HBSS and exposed
boxy-2′, 7′-dichlorodihydrofluorescein) was monitored by fluorescent microscopy.
Fig. 2. Effects of selenite on gene expression in NPCs after H2O2 treatment. We
analyzed functional gene expression in cultured NPCs in the presence or absence
of selenium before H2O2 treatment; these genes included several kinds of
MMPs, SDF1, and stem cell and neural lineage related markers (Nestin, TrkB,
FGFR2, GDNF, GFAP and TuJ).
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were equilibrated in 30% sucrose for 48 hr and embedded in Tissue-Tek OCT
(optimal culture temperature) compound (Miles, Elkhart, IN), and then frozen
at −20 °C. Cryostat sections (10 μm) were cut through the brain using a
freezing microtome (CM3050; Leika Microsystems), mounted on poly-D-
Lysine-coated slides (Sigma); and air-dried overnight at 37 °C. The tissue
sections were stained with hematoxylin and eosin (H&E, Sigma) and were
examined and photographed with a phase contrast microscope (Nikon
Microsystems). For analysis of protein upregulation in injured brain, tissues
at the center of the lesion were incubated with overnight at 4 °C with primary
antibodies against anti-ED-1 (1:100, Serotec. UK), anti-TuJ (1:250, Sigma,
USA), and anti-GFAP (1:2000, DAKO Cytomation, Denmark). After extensive
washing with PBS, the tissue sections were incubated for 30 min with FITC
and Texas-Red secondary antibodies (1:250, Molecular Probe, USA). Cell
nuclei were labeled with Topro-3 (Molecular Probe, USA). The results were
analyzed using a Confocal Microscopy (Leica Microsystems, PA) using a
Leica TCS sp2 laser scanning microscope equipped with 3 lasers.
Immunohistochemical experiments were repeated at least three times.
Immuno-positive cells in nearby lesion site (cortex and hippocampus) were
quantified by counting of stained cells. Three digital microscopic images at a
magnification of 100× were randomly captured at the areas where the positive
cells. The number of positively stained cells in the three images was averaged.
Three sections at each of the tissue samples were examined by an observer
blind to the treatment and the mean value of cell counting was used to
represent one single tissue sample. The result was expressed as relative cells
percentage per view field. The size of the view field was 0.075 mm2. Traumatic
brain nerve cells staining were performed using 0.25% of Cresyl Echt Violet
(Sigma). Cresyl Echt Violet Staining was performed with serial 10 μm tissue
slide of brain (4-week post-injury or HBSS injected) and selenite treated were
fixed in 95% ethanol, 0.5% acetic acid for 1 h. For each brain tissue slide,
samples were harvested at 500 μm intervals to yield 20 sections per brain.
Stained sections were viewed on phase contrast microscope. Stained sections
around the injury lesion were digitally imaged, and the area of Cresyl Echt
Violet staining was analyzed.
2.12. Statistical analysis
All data were presented as mean±S.E.M. from five or more independent
experiments. The statistical significance of difference between groups was
calculated by using the Student's two-tailed t-test.3. Results
3.1. Sodium selenite protects neural progenitor cells from
H2O2-induced apoptotic cell death and affected cell
growth
H2O2-induced cell death was apparent in the 2-day culture
of neural progenitor cells, but was not observed in cultures
pretreated with 2 ng/ml selenium (Fig. 1A). In cultures
pretreated with sodium selenite (2 ng/ml), over 60% of the
neural progenitor cells survived against 0.05 μM/ml H2O2-
induced apoptotic cell death (Fig. 1A). Cultured neural
progenitor cells were able to grow in medium containing
2–5 ng/ml selenium before treatment with 0.03 μM and
0.05 μM H2O2 (Fig. 1A). Also, the neural progenitor cells
grew well from the second to the fifth day, with 2 ng/ml
sodium selenite pretreatment being the optimal concentration
for optimum cell growth (supplementary Fig. 2). Cell survival
requires active inhibition of apoptosis, which is accomplished
either by inhibiting cell death through prevention of DNA
breakage (Fig. 1B) or through activation of functional
survival proteins.3.2. Effect of selenite on gene expression of neural precursor
cells after H2O2 treatment
Selenite exerted prominent effects on the expression of
various functional genes, including that of several MMPs
(matrix metallo-proteases), SDF1 (stem cell migration-related)
and stem cell and neural lineage-related markers (Nestin, TrkB,
FGFR2, GDNF, GFAP, and TuJ), in neural progenitor cells
(NPCs) cultured in the presence or absence of selenium before
H2O2 treatment. Selenium protected against H2O2-induced
cytotoxic damage and did not significantly alter the basal levels
of GDNF, Nestin, TuJ, MMP2, EGF, and PDGFα mRNA,
whereas it decreased the amounts of GFAP, TrkB, SDF1,
MMP1, and FGFR2 mRNA at a concentration of 2 ng/ml
selenium (Fig. 2). Our results revealed that selenium protected
Nestin-positive neural stem cells and TuJ-positive neurons
against H2O2-induced apoptotic cell death. In contrast, GFAP-
positive astrocytes were more sensitive to H2O2 and were not
protected by selenium pretreatment. According to our prelim-
inary experiments, sodium selenite (2 ng/ml) alone in NPCs had
no significant effect on the expression of these genes (data not
shown).
3.3. Sodium selenite induced cell survival against
H2O2-mediated cell death via modulation of P38, p-SAPK/
JNK, Bax, Bcl-2 expression in vitro and in vivo
Cell survival requires active inhibition of apoptosis, which is
accomplished either by inhibition of cell death through
prevention of DNA breakage (Fig. 1B) or by activation of
functional survival proteins. When cells were pretreated with
selenite, survival and proliferation factors caused the activation
and upregulation of p-Akt, p-ERK1/2, Bcl-2, thioreduction
reductase 1 (TR1), GFAP, and TuJ proteins in the NSC cultures.
Fig. 3. Effect of selenite onH2O2-induced apoptotic/survival signal protein expression in cultured neural progenitor cells. To confirm differential expression of apoptotic
or cell survival signal proteins (A) and neural markers (B) in the presence or absence of selenium before H2O2 treatment over a time course (0, 12, 24 h), cultured cells
were pooled and lysed in 500 μl of lysis buffer. Lysates were clarified by centrifugation at 15,000×g for 10 min and the total protein content was determined using a Bio-
Rad (Milan, Italy) protein assay kit.
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JNK, Bax, and caspase 3 and 9 (Fig. 3A and C). Selenite-
attenuated activation of mitochondria-mediated cell death was
related to modulation of caspase 3 and 9 activity, cytochrome c
release, and PARP cleavage (Fig. 3A and C). To determine the
in vivo neuroprotective function of sodium selenite, we used a
mouse brain traumatic injury model. Traumatic brain injury and
H2O2 treatment in NPC cells induced P38 and JNK/SAPK
activation after 3 days in vivo and after 24 h in vitro (Figs. 3A,
5A). One week after injury, selenium-treated animals exhibited
Bcl2 and thioredoxin reductase (TR1) up-regulation, prominent
increases of the neural marker, TuJ, decreased ED1 and GFAP
expression (Fig. 5B, C), as well as down-regulation of P38
and p-JNK/SAPK expression after 3 days (Fig. 5A). This result
reveals that sodium selenite prominently attenuated the
mitochondria-mediated cell death signaling pathway and p38/
JNK/SAPK-induced cell death signaling. Finally, selenitenegatively regulated neuronal cell death in injured brain tissue
and induced neural differentiation. Moreover, sodium selenite
attenuated activation of mitochondria-mediated cell death
proteins via modulation of caspase 3 and 9 activity and cy-
tochrome c release in vivo (Fig. 5D and A). Our results suggest
that selenite prominently attenuated mitochondria-mediated cell
death signaling pathways and protected against neuronal cell
death in the injured brain tissue.
3.4. Sodium selenite modulates H2O2-induced apoptotic
properties in cultured neural progenitor cells
Hydrogen peroxide (H2O2) has been shown to increase
cellular oxidative stress. We evaluated the effects of selenite on
ROS production after treating cultured neural progenitor cells
with H2O2. Hydrogen peroxide increased the oxidation of DCF
in a concentration-dependent manner and the increased DCF
Fig. 4. Effect of selenite on H2O2-induced ROS and ATP generation in cultured neural progenitor cells. (A) Intracellular ROS in cultured NPCs was evaluated using the
fluorescent probe DCFDA in the presence or absence of selenium before H2O2 treatment.
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selenite (Fig. 4A). Selenite alone did not significantly alter ROS
production (0.64% ROS generation after selenite treatment
in control cells), but selenite decreased H2O2-induced ROS
production from 13.40% to 3.34% (Fig. 4A). We also examined
whether selenite could inhibit the release of cytochrome c from
mitochondria in selenite-treated cells. Western blot analysis
showed that while the H2O2-treated cells released most of their
cytochrome c into the cytosol, cells preincubated with selenite
released less of their cytochrome c into the cytosol (Fig. 3A),
indicating that selenite prevented H2O2-induced cell death by
maintaining mitochondrial integrity. Because H2O2 triggers the
activation of caspase 3 and 9, we also examined whether sel-
enite can inhibit caspase 3 and 9 activation after H2O2-treatment
of NSC cells. In response to H2O2 exposure, caspase 3 activity
increased by approximately 1.8-fold; selenite treatment signif-
icantly attenuated the H2O2-elicited caspase activation (Fig. 3C).
We also evaluated ATP production in selenite/H2O2-treated
cells. In response to H2O2 exposure, ATP production decreased
prominently, but in selenium-pretreated cells, ATP productionability was essentially recovered 24 h after H2O2 exposure (Fig.
4B). Together, these findings indicate that selenite inhibits
H2O2-induced apoptotic features in brain subventricular zone-
derived neural progenitor cells.
3.5. Sodium selenite attenuated apoptotic cell death in lesion
site of injured brain
Before and after administration of selenite mixed with
matrigel into the lesion site, injury-induced cell death was
demonstrated by TUNEL staining. As shown in Fig. 6,
considerable numbers of TUNEL-positive cells were observed
in the lesion site 1 week after traumatic injury. In contrast,
selenite treatment effectively prevented the injury-induced
TUNEL-positive cells (Fig. 6). Western blot analysis revealed
prominently downregulated mitochondria-mediated apoptotic
cell death proteins such as cleaved PARP and Bax as well as
decreased cytochrome c release, with highly increased Bcl2
survival protein in the cytosolic compartment of selenium-
treated injured brain compared to untreated brain (Fig. 5A).
Fig. 5. The neuroprotective function of sodium selenite in traumatic mouse brain injury. (A) Differential expression of the apoptotic signaling proteins at the lesion site
after 1 week of sodium selenite treatment in mouse brain. To confirm differential expression of signal proteins and (B) several neural markers after selenite treatment,
tissues at the center of the lesion were isolated from the injured brain and analyzed. Relative band intensities were determined using Quality-one 1-D analysis software.
(C) To analyze astrogliogenesis and microglia and macrophage activation after selenite treatment in injured brain, tissues at the center of the lesion were incubated with
primary antibodies against GFAP and ED. Cell nuclei were labeled with Topro-3. The results are expressed as relative cell percentage per view field. The size of the
view field was 0.075 mm2. The dotted line shows the boundary of the brain lesion site. The circled area indicates the lesion site used to count GFAP- and ED1-positive
cells. (D) After 1 week of selenium treatment (or untreated control), we performed caspase activity assays using protein derived from tissue at the lesion site.
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and striatum regions does not express apoptosis-related signal
proteins (data not showed). In addition, compared to the
untreated group, the selenium-treated group exhibited promi-nently preserved TuJ-positive neurons and attenuated glial scar
formation (GFAP-positive) (Fig. 5B and C). This result revealed
that sodium selenium effectively protected neurons from
apoptotic cell death after traumatic brain injury.
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gliogenesis
To determine whether selenite inhibits posttraumatic astro-
gliosis, the number of GFAP-positive glia in the two
experimental groups were compared. Cortex surrounding the
lesions was sliced into 3-μm thick sections and quantitatively
examined for GFAP-positive glial cells in the white matter
region. There were 3.84 ± 2.0 astroglia per 20 μm2 of tissue in
the selenite-treated group vs. 18.0±1.7 astroglia per 20 μm2 of
tissue in the untreated control group (Fig. 5C). The number of
GFAP-immunopositive cells in the ventral funiculi demonstrat-
ed an overall significant effect on reducing reactive astrogliosis
(Fig. 5B, C). In contrast to the GFAP/TOPRO3-positive
population (%), there were significantly more TuJ/TOPRO3-
positive neurons (%) around the lesion site (Fig. 5C). Cresyl
echt violet staining was performed at the lesion site in the
injured brains to detect neurons (Fig. 6). In normal brains and in
selenite-treated mice, the violet groups of nerve cells indicated
the prevention of neuronal death. In contrast, in the traumatic
brain injury control group, cresyl echt violet staining in the
same area was very weak. Selenite treatment greatly improved
TuJ expression around the lesion site in the selenite/trauma-
administered group as an indicator of neuroprotection after
insult (Fig. 5B). Selenite treatment also reduced the loss ofFig. 6. The effect of sodium selenite on neuroprotection in traumatic brain injury
(A) Representative micrographs of the lesion in normal and injured animals following
traumatic brain injury in selenium-treated or untreated tissue, nerve cells were stained
apoptosis by traumatic brain injury was determined with the TdT in situ apoptosis dete
using a FluorescenceMicroscope (Leica Microsystem, PA). TUNEL-positive apoptoticneurons in the injured cortex and hippocampus. Cresyl echt
violet staining in the lesions of control injured brain tissue was
completely lost, while the loss was not observed in the normal
and selenite-treated animals (Fig. 6). Finally, selenite treatment
reduced and attenuated neuron death at the lesion sites. The
overall cross section profiles of the lesion epicenters from the
normal, control, trauma, and selenite/trauma animals were
comparable. We also evaluated whether selenite treatment
reduced lesion volume. We outlined the lesion area in transverse
sections of brain samples from the lesions and adjacent tissue.
The transverse lesion lengths indicated that selenite significant-
ly affected the lesions. The lesions may also have been
influenced by the possible neuroprotective properties of
selenite. We observed a dose-dependent effect of selenite (0,
10, 30, 50 μg/kg) on the expression of caspase 3, caspase 8,
caspase 9, and PARP by staining TUNEL-positive cells at the
injury epicenter. At 10 ng/kg, selenite significantly reduced
caspases and PARP expression to negligible pre-trauma levels
(data not shown).
3.7. Effect of selenite on macrophage and microglia infiltration
in traumatic brain injuries in a mouse model
Sham-operated or control brain trauma animals and selenite-
treated (10 μg/kg) animals were evaluated 6 days after surgery. Sodium selenite attenuated apoptotic cell death after traumatic brain injury.
staining with cresyl echt violet and Luxol fast blue, respectively. One week after
with 0.25% cresyl echt violet solution. (B) The effect of selenite on induction of
ctor kit according to the manufacturer's specifications. The results were analyzed
cells in traumatic brain lesions were quantified by counting positively stained cells.
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control and experimental groups in the expression of ED-1
protein during the examination period. The expression of ED-1
antigenic protein level decreased remarkably after selenite
treatment (Fig. 5B). Indeed, selenite treatment had a direct effect
on macrophage invasion. Traumatic injury activated both
macrophage and microglia at the lesion sites as indicated by
the ED-1 immunohistochemistry, which showed that the number
of activated macrophages increased significantly. They were
darkly stained with round, sharp and blunt processes in the tissue
around the lesion sites 1 week after injury (data not shown).
4. Discussion
Oxidative stress and generation of reactive oxygen species
(ROS) are strongly implicated in a number of neuronal and
neuromuscular disorders, including stroke, cerebrovascular
disease, Alzheimer's disease, Parkinson's disease, familial
amyotrophic lateral sclerosis, and Duchenne muscular dystro-
phy [25–32]. Selenium is known to provide protection from
ROS-induced cell damage, and the proposed mechanism mainly
invokes the functions of glutathione peroxidases (GPxs) and
selenoprotein P (SelP). Selenium/selenite has been linked to
regulatory functions in cell growth, survival, and cytotoxicity,
as well as transformations possibly involving redox regulation,
chemical toxicity and the transcriptional regulation of various
genes (Lee et al., 2000). In a recent study, we also found a
significant protective effect of sodium selenite against hydrogen
peroxide (H2O2)-induced NPC death in an in vitro culture
system (Fig. 1). Selenite-induced protection and survival of
NPCs involved continued expression of cell migration and stem
cell function-related genes such as MMP2, SDF1, GDNF,
PDGFRα, and Nestin after H2O2 exposure (Fig. 2). Our RT-
PCR results also showed that selenite especially protects
Nestin-positive neural precursor cells and TuJ-positive neurons
against ROS-mediated apoptotic cell death (Fig. 2). The precise
biochemical action of selenite, however, is not yet fully
understood. Thioredoxin reductase and thioredoxin form a
redox system that has multiple roles, including redox regulation
of transcription factors and provision for reducing equivalents
for synthesizing deoxyribonucleotides for DNA synthesis.
Selenium induces mitochondrial permeability transition by
modification of protein thiol groups, which results in cyto-
chrome c release and loss of mitochondrial membrane potential
[33]. We provide experimental support for the hypothesis that
selenite may play a pivotal role in the anti-oxidation responses,
in part by significantly inhibiting production of ROS, an
important mediator in the pathophysiology of inflammatory
disease such as acute brain trauma (Fig. 4A). Activation of both
resident and recruited immune cells appears to be the cellular
source for up-regulation of these cytokine mRNAs in SCI-
induced CNS inflammation [34]. Macrophages play important
roles in the removal of myelin debris and the products of
neuronal degeneration after trauma, infection, or autoimmune
reactions in the neuronal system. Recent evidence [34] indicates
that this activation may account for apoptosis induced by
proinflammatory cytokines. It is apparent that the inflammatoryresponse to LPS in macrophages includes the initial induction of
ROS in macrophages, which leads to activation of MAPKs and
NFκB and to the induction of iNOS and inflammatory
cytokines. This last step leads to production of toxic amounts
of NO, together with toxic cytokines. Selenite can alleviate
these effects by antioxidant action and by modulating the
downstream pathway. Our results suggest that the selenite-
modulated pathway involves Bax and cytochrome c, while p38/
JNK and PARP-specific ERK showed little involvement in
the in vitro cultured NPCs and in vivo traumatic brain lesion
(Figs. 3A, B, 5A, B). The short-term effect of selenite is mainly
anti-apoptotic. Cellular damage from ROS was greatly
alleviated by selenite treatment. Selenite incubation resulted
in lower levels of intracellular ROS and prevention of p38,
SAPK-JNK, and Bax activation in in vitro cultures (Fig. 3). An
important intracellular signal transduction pathway that leads to
apoptosis after brain trauma involves activation of MAPKs and
caspases. Recent studies with in vivo and in vitro models of
CNS trauma demonstrate that MAPKs are activated in response
to mechanical forces. Both c-Jun N-terminal kinase (JNK) and
extracellular signal-regulated kinase (ERK 1/2) are known
regulators of cell survival/death, and activation of ERK 1/2 was
linked to cell survival [35,36]. Activated JNK was evident in
both apoptotic neurons and oligodendrocytes following com-
pressive spinal cord injury [37], and delayed neuronal death
following global cerebral ischemia was preceded by a sustained
increase in activated JNK [38]. In contrast to JNK, activated
ERK 1/2 may be involved in the regulation of axonal growth
[39], in the protection against cytosine arabinoside-induced
apoptosis [40], and in neuroprotection in a model of ischemic
preconditioning [41]. Ebselen also reported inhibition of NO-
induced apoptosis of differentiated PC12 cells via inhibition of
ASK1-p38, MAPK-p53 and JNK signaling and via activation of
p44/42MAPK and Bcl2 [42]. Our results show that ERK, P38,
and JNK were consistently activated by traumatic brain injury
(Fig. 5A). When selenite was used to treat NPCs and in vivo
traumatic brain injuries, p38 and JNK activation was decreased
(Figs. 3A, 5B). After H2O2 treatment in NPCs and cortical
impact injuries in mice, ERK phosphorylation increased at the
lesion sites and in the cells (Fig. 5B). After treating the
traumatic brain injuries and the reactive oxygen-damaged cells
with selenite, ERK activation increased greatly (Figs. 3B, 5B),
suggesting a beneficial role for ERK in functional neural
recovery. Furthermore, disrupting the balance between pro- and
anti-survival MAP kinases following CNS injury may lead to
cell death.
Likewise, Akt is an important signaling mediator of cell
survival, metabolism, and cell cycle progression [43,44]. The
PI3K/Akt signaling pathway promotes cell survival by
phosphorylating and inactivating pro-apoptotic proteins. Acti-
vated Akt can also inhibit JNK activity in cells where JNK
mediates apoptosis. Akt activation has been observed in
cultured NPCs after treatment with H2O2. Compared to control,
selenium-treated cells exhibited a large increase in the
expression of phospho-Akt molecules (Fig. 3B). Highly
activated Akt may modulate JNK activities that mediate cell
death and ultimately induce an escape from apoptotic cell death.
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injury, was also effectively prevented (Fig. 3C). The present
study extends these observations to the brain lesion site by
providing the first evidence that up-regulation of Bcl2 protein
also plays an important role in the execution of apoptosis in
brain trauma. Activated caspase-3 protease contributes to the
execution of apoptosis. In addition, cleavage of the DNA repair
enzyme PARP during apoptosis not only blocks DNA repair,
but also preserves cellular pools of ATP that may be necessary
for execution of the cell death program. Compared with
untreated control brain, the tissue lesions in selenite-treated
brains showed significant decreases in the total amount of PARP
and Bax apoptotic proteins and in cytochrome c released, and
increases in the expression of Bcl2, an anti-apoptotic survival
protein (Fig. 5A). Selenite effectively blocked ROS-mediated
apoptotic cell death (TUNEL-positive) in the lesion site (Fig. 6).
The foremost protective effect of selenite in brain trauma would
therefore manifest in suppression of acute secondary apoptotic
cell death. Indeed, selenite treatment prevented the elevation of
ROS generation in cultured NSCs after H2O2 treatment and
protected against neuronal cell (TuJ-positive) death, which is
seen prominently in mouse brain trauma (Fig. 5B and C).
Selenite also attenuates active microglia and macrophage
infiltration very efficiently (Fig. 5B). This finding supported
the prominent histopathological changes, such as attenuation of
glial scar formation, observed in the lesion area in selenite-
treated mouse brains (Fig. 5C). Moreover, selenite-mediated
neuroprotection has been linked to its attenuation of p38
mitogen-activated protein kinase, pSAPK/JNK (Fig. 5A).
Our data show that the therapeutic outcome of selenite
treatment most likely resulted from its comprehensive preven-
tion of apoptotic cell death, thus protecting neurons and
inhibiting microglial and macrophage cell activation (Figs. 5
and 6). Selenite inhibits the processes of apoptotic cell death at
the brain lesion site and is suggested to be responsible for
delayed cell death in cortical and hippocampal pathology (Figs.
5 and 6). Selenite significantly attenuated cortical damage and
increased neuron survival at the brain lesion sites. Moreover,
there was a remarkable reduction in reactive astrogliosis in the
lesioned cortex (Fig. 5B and C). Reactive astrocytes secrete
inhibitory molecules such as neurocan and trabecular mesh-
work-inducible glucocorticoid response protein (TIGR) to
restrict motor neuronal repair and regeneration [45,46].
The contribution of selenite to the reduction of apoptotic cell
death and prevention of neuronal destruction in the cortex and
hippocampus following traumatic injury require further study in
order to fully elucidate a mechanism. The findings that selenite
prevents secondary pathological events in traumatic brain
injuries in an animal model may provide novel drug targets for
treating brain trauma.
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